XBIOTECH INC. Income Taxes Receivable, Current
XBIOTECH INC. (XBIT) had Income Taxes Receivable, Current of $14.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Nontrade Receivables, Current
us-gaap:IncomeTaxesReceivable · last filed 2026-08-13
- 2026-06-30: Income Taxes Receivable, Current $14.00K.
- 2025-12-31: Income Taxes Receivable, Current $0.00.
- 2025-09-30: Income Taxes Receivable, Current $75.00K.
- 2025-06-30: Income Taxes Receivable, Current $158.00K.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2026-06-30 | $14.00K 10-Q · filed 2026-08-13 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-13 |
| 2025-09-30 | $75.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $158.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $158.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $158.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | $141.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $123.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $75.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $75.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | $451.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $577.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $548.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $548.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $1.18M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $12.43M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $10.03M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $8.95M 10-K · filed 2023-03-15 |
| 2021-09-30 | $10.40M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $8.11M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $3.35M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $6.57M 10-K · filed 2022-03-15 |
| 2020-09-30 | $6.11M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $4.97M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $3.79M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |